Literature DB >> 6600236

Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies.

R S Geha, M Comunale.   

Abstract

The effect of rabbit antiidiotypic antibody raised against human IgG F(ab')2 anti-tetanus toxoid (TT) antibodies on the in vitro synthesis of TT-specific IgE antibody by peripheral blood lymphocytes (PBL) was examined in three subjects. Two of these subjects were allergic twins whose sera persistently contained IgE anti-TT antibodies. The third subject was a nonallergic individual who had a slightly elevated serum IgE (250 IU/ml) and who exhibited a transient serum IgE anti-TT response after booster immunization with TT. After appropriate absorptions rabbit anti-idiotype (Id) IgG reacted with anti-TT antibodies of both IgG and IgE isotypes in an idiotype- and antigen-specific fashion. PBL and B cells from the three subjects studied spontaneously synthesized TT-specific IgE in culture. In all three cases, adsorption of B cells over plastic plates coated with anti-Id before culture specifically decreased the synthesis of IgE antibodies to TT but did not affect the synthesis of IgE antibodies to ragweed antigen E by PBL from the twin allergic subjects. Addition of anti-Id to cultures of PBL from all three subjects specifically inhibited the synthesis of TT-specific IgE. This inhibition was shown to be exerted both at the level of the B cells and via the generation of antigen-specific suppressor T cells from radiosensitive precursors. The present results indicate that the synthesis of antigen-specific IgE in man is subject to regulation by idiotypic anti-idiotypic interactions that can involve both B and T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600236      PMCID: PMC436836          DOI: 10.1172/jci110750

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Production of human immunoglobulin E antibody in vitro.

Authors:  A H Tjio; W M Hull; G J Gleich
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

Review 2.  Cellular events in the IgE antibody response.

Authors:  K Ishizaka
Journal:  Adv Immunol       Date:  1976       Impact factor: 3.543

3.  Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cells.

Authors:  J Z Weinberger; R N Germain; S T Ju; M I Greene; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

4.  Ontogeny of IgE-bearing lymphocytes in the rat.

Authors:  K Ishizaka; T Ishizaka; H Okudaira; H Bazin
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

5.  IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (Td) toxoids.

Authors:  J Nagel; D Svec; T Waters; P Fireman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

6.  IgE response to synthetic polypeptide antigens. II. Idiotypic analysis of the IgE response to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT).

Authors:  A Dessein; S T Ju; M E Dorf; B Benacerraf; R N Germain
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

7.  Anti-idiotypic antisera in man. I. Production and immunochemical characterization of anti-idiotypic antisera to human antitetanus antibodies.

Authors:  R S Geha; R P Weinberg
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

8.  Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype.

Authors:  C Bona; W E Paul
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

9.  Mechanisms of regulation of cell-mediated immunity. IV. Azobenzenearsonate-specific suppressor factor(s) bear cross-reactive idiotypic determinants the expression of which is linked to the heavy-chain allotype linkage group of genes.

Authors:  B A Bach; M I Greene; B Benacerraf; A Nisonoff
Journal:  J Exp Med       Date:  1979-05-01       Impact factor: 14.307

10.  Antigen-specific helper factor in man.

Authors:  F B Mudawwar; E J Yunis; R S Geha
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE.

Authors:  C G Magnusson; S G Johansson
Journal:  Clin Rev Allergy       Date:  1989

Review 2.  Human IgE biosynthesis in vitro.

Authors:  G Del Prete; E Maggi; S Romagnani; M Ricci
Journal:  Clin Rev Allergy       Date:  1989

3.  Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.

Authors:  J J Machiels; M A Somville; P M Lebrun; S J Lebecque; M G Jacquemin; J M Saint-Remy
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 4.  Novel approaches in immunotherapy.

Authors:  J M Saint-Remy
Journal:  Clin Rev Allergy       Date:  1994

Review 5.  Suppression of autoimmune diseases with anti-idiotypic antibodies: murine lupus nephritis as a model.

Authors:  B H Hahn
Journal:  Springer Semin Immunopathol       Date:  1984

Review 6.  Immunological response to immunotherapy for immediate hypersensitivity: clinical relevance.

Authors:  R Tamir; A I Pick
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

7.  Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an antiidiotypic antibody directed to an interspecies cross-reactive idiotype expressed on antifibrinogen antibodies.

Authors:  A Ruiz-Arguelles
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

8.  Anti-IgE autoantibody in patients with bronchial asthma.

Authors:  Y Nawata; T Koike; T Yanagisawa; I Iwamoto; T Itaya; S Yoshida; H Tomioka
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements.

Authors:  W J Koopman; R E Schrohenloher; J C Barton; E C Greenleaf
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

10.  Actual therapeutic management of allergic and hyperreactive nasal disorders.

Authors:  Claudia Rudack
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2004-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.